Anzeige
Mehr »
Login
Dienstag, 30.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Basin Uranium: Es geht los! Der Uran-Superzyklus ist gestartet!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
21 Leser
Artikel bewerten:
(0)

Styrenic Polymers Market for Medical Applications - Global Industry Analysis 2014 - 2020: Major Companies are Styrolution Group GmbH, Saudi Basic Industries, Chi Mei, LG Chem Ltd. and Kraton Polymers.

DUBLIN, Feb. 23, 2015 /PRNewswire/ --Research and Markets

(http://www.researchandmarkets.com/research/7ww2c3/styrenic_polymers) has announced the addition of the "Styrenic Polymers Market for Medical Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering.

600769

The global styrenic polymers market for medical styrenics is likely to expand at a CAGR of 6.5% from 2014 to 2020.

Styrenic polymers offer several desirable product characteristics to cater to the diverse requirements of the medical industry. Styrenic materials can be processed to be rigid as well as flexible, as per end-user requirements. Owing to its flexibility, styrenic polymers offer unique advantages in design and development of medical devices and parts. Properties such as chemical inertness, unique bonding polarity, and physical and aesthetic properties boost the styrenic polymers market in medical applications. However, styrenic polymers are higher priced compared to other medical polymers such as polyvinyl chloride (PVC), and polyethylene (PE). This hampers the market from achieving higher growth, especially in price sensitive markets, to some extent.

North America accounted for the largest market share (39.9%) of styrenic polymers for medical applications in 2013. The styrenic polymers market for medical applications in North America was followed by Asia Pacific and Europe in 2013. Asia Pacific is likely to record the fastest growth in the global market for medical styrenics during the forecast period. Rapid increase in the geriatric population across the world coupled with constant improvement and innovation in the medical industry is projected to provide ample opportunity for the growth of styrenic polymers market for medical applications.

The global styrenic polymers market for medical applications is moderately concentrated in nature. Major companies operating in the market include Styrolution Group GmbH, Saudi Basic Industries Corporation, Chi Mei Corporation, LG Chem Ltd. and Kraton Polymers.

Key Topics Covered:

Chapter 1 Preface


Chapter 2 Executive Summary

Chapter 3 Styrenic Polymers Market for Medical Applications - Industry Analysis

Chapter 4 Styrenic Polymers Market for Medical Application - Product Segment Analysis

Chapter 5 Styrenic Polymers Market for Medical Applications - Regional Analysis

Chapter 6 Company Profiles

- Americas Styrenics LLC
- Bayer MaterialScience AG
- Chevron Phillips Chemical Company LLC
- Chi Mei Corporation
- INEOS ABS (USA) Corporation
- Kraton Polymers LLC
- LG Chem Ltd
- Nova Chemicals Corporation
- Saudi Basic Industries Corporation
- Styrolution Group GmbH
- Styron LLC (Trinseo S.A.)

For more information visit http://www.researchandmarkets.com/research/7ww2c3/styrenic_polymers

Media Contact:
Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.